keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mifamurtide sodium is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults. It was approved in Europe in March 2009.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Mifamurtide sodium is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults. It was approved in Europe in March 2009. |
Synonyms | Muramyl tripeptide, CGP 19835A, L-MTP-PE, Mepact, Junovan |
Molecular Weight | 1260.508 |
Formula | C59H109N6NaO19P |
CAS No. | 90825-43-7 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mifamurtide sodium 90825-43-7 Muramyl tripeptide CGP 19835A L-MTP-PE Mepact Junovan inhibitor inhibit